French study registry for infective endocarditis patients
Part of Heart & circulation clinical trials.
This trial is a national hospital registry that collects information from people hospitalized with suspected infective endocarditis (an infection of the heart lining or valves). It may help doctors better classify cases and improve care by analyzing real-world patient data.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be treated or followed at a participating hospital center
- After your hospital data is reviewed, your case must meet the study’s heart-infection criteria (definite or possible)
- You must be enrolled in the French social security system
- You must agree to take part (no refusal)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a registry that collects information from people with infective endocarditis, a heart infection. By joining, you help researchers learn more about the condition and improve future care.
This study keeps a detailed record of adults with infective endocarditis (a serious heart valve infection) who are undergoing cardiac surgery. The information may help doctors understand patterns of care and outcomes, and improve future treatment decisions.
This is an observational study that follows people with confirmed infective endocarditis (a serious infection of the heart lining or heart valves). It may help doctors better understand the illness and improve care.
This study gathers information from patients with a heart infection called endocarditis to help doctors better understand and treat the condition. Anyone aged 16 or older with confirmed or suspected endocarditis who is being treated at Barts Heart Centre may be able to join.
This study collects medical information and optional biological samples (like blood or saliva) from people with an active or suspected infection. The goal is to build a large database that can help researchers better understand infectious diseases and develop new ways to diagnose and treat them.
This study looks at blood and other lab test results (“biomarkers”) to better predict what may happen to people with infective endocarditis, a serious infection of the heart lining or heart valves. Your information may help doctors estimate risk and choose care more safely and effectively.
Hear when a new Infective Endocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.